课题基金 / 基金详情

LONGTERM TOLERABILITY, SAFETY AND EFFICACY OF ORAL RIDOGREL IN ULCERATIVE COLITIS

LONGTERM TOLERABILITY, SAFETY AND EFFICACY OF ORAL RIDOGREL IN ULCERATIVE COLITIS
口服利多格雷治疗溃疡性结肠炎的长期耐受性、安全性和有效性
批准号：
6121132
负责人：
ALAN L. BUCHMAN
金额：
$1.51万
依托单位：
UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON
依托单位国家：
美国
项目类别：
财政年份：
1998
资助国家：
美国
项目状态：
已结题
起止时间：
1998-12-01 至 1999-11-30
来源：
https://reporter.nih.gov/project-details/6121132
关键词：
clinical research drug screening /evaluation endoscopy enzyme inhibitors gastrointestinal agents gastrointestinal disorder chemotherapy health care cost /financing histology human subject human therapy evaluation oral administration quality of life remission /regression ulcerative colitis

项目摘要

项目成果

ALAN L. BUCHMAN的其他基金

相关文献

中文摘要
翻译
这项研究是一项开放标签的多中心试验，针对在先前的利多格雷与安慰剂研究中未能完全缓解活动性溃疡性结肠炎（UC）的患者。它将确定长期（24个月）每日5mg利多格雷治疗的安全性和有效性。患者将通过主观症状评估、内镜和组织学参数、生活质量评估、安全性和总体成本效益进行评估。
英文摘要
This study is an open-label multicenter trial for patients who fail to achieve complete remission of their active ulcerative colitis (UC) in a previous study of ridogrel vs placebo. It will determine the safety and efficacy of long-term (24 months) treatment with ridogrel, 5 mg daily. Patients will be evaluated by subjective symptom evaluation, endoscopic and histologic parameters, quality of life assessment, safety, and overall cost effectiveness.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
TREATMENT OF HEPATIC STEATOSIS ASSOCIATED WITH TOTAL PARENTAL NUTRITION
USE OF CLONIDINE TO REDUCE DIARRHEA LOSSES IN PATIENTS WITH PROXIMAL JEJUNOSTOMY
USE OF CLONIDINE TO REDUCE DIARRHEA LOSSES IN PATIENTS WITH PROXIMAL JEJUNOSTOMY
SAFETY AND EFFICACY OF ISIS 2302 IN STEROID DEPENDENT CROHN'S DISEASE